image
Anebulo Pharmaceuticals, Inc. ANEB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.5884
4.5 %
$ 41.2 M
Market Cap
-4.96
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-06-30 0.00% 30.09% 29.49%
Annual Report FY 10-K 2023-06-30 0.00% -72.21% -72.50%
Annual Report FY 10-K 2022-06-30 0.00% 77.49% -89.03%
Annual Report FY 10-K 2021-06-30 0.00% -17229.26% -1984.66%
Annual Report FY 10-K 2020-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2024-09-30 0.00% 11.29% 5.17%
Quarterly Report Q4 8-K 2024-06-30 0.00% 45.91% 46.26%
Quarterly Report Q3 8-K 2024-03-31 0.00% 39.47% 41.89%
Quarterly Report Q2 8-K 2023-12-31 0.00% 29.25% 27.61%
Quarterly Report Q1 8-K 2023-09-30 0.00% 5.02% 2.62%
Quarterly Report Q4 8-K 2023-06-30 0.00% -7.66% -7.26%
Quarterly Report Q3 8-K 2023-03-31 0.00% -45.83% -52.37%
Quarterly Report Q2 8-K 2022-12-31 0.00% -257.95% -255.99%
Quarterly Report Q1 8-K 2022-09-30 0.00% -68.14% -67.99%
Quarterly Report Q4 8-K 2022-06-30 0.00% 92.04% 6.41%
Quarterly Report Q3 8-K 2022-03-31 0.00% -237.03% -240.43%
Quarterly Report Q2 8-K 2021-12-31 0.00% -226.53% -230.01%
Quarterly Report Q1 8-K 2021-09-30 0.00% -505.90% -516.19%
Quarterly Report Q4 8-K 2021-06-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2021-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2020-09-30 0.00% 0.00% 0.00%